Cliff Asness's GOSS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 10.13 M shares of Gossamer Bio, Inc. (GOSS) worth $3.33 M, representing 0.00% of the portfolio. First purchased in 2022-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in GOSS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 9.01 M shares. Largest reduction occurred in Q1 2023, reducing 14,473 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Gossamer Bio (GOSS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gossamer Bio (GOSS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +9.01 M | Add 804.80% | 10.13 M | $0.33 |
| Q4 2025 | +472,625 | Add 73.09% | 1.12 M | $3.10 |
| Q3 2025 | +646,615 | New Buy | 646,615 | $2.63 |
| Q1 2023 | -14,473 | Sold Out | 0 | $0.00 |
| Q4 2022 | +14,473 | New Buy | 14,473 | $2.17 |
Cliff Asness's Gossamer Bio Investment FAQs
Cliff Asness first purchased Gossamer Bio, Inc. (GOSS) in Q4 2022, acquiring 14,473 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Gossamer Bio, Inc. (GOSS) for 5 quarters since Q4 2022.
Cliff Asness's largest addition to Gossamer Bio, Inc. (GOSS) was in Q1 2026, adding 10,126,897 shares worth $3.33 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 10,126,897 shares of Gossamer Bio, Inc. (GOSS), valued at approximately $3.33 M.
As of the Q1 2026 filing, Gossamer Bio, Inc. (GOSS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Gossamer Bio, Inc. (GOSS) was 10,126,897 shares, as reported at the end of Q1 2026.